Nerve Block of the Proximal Interphalangeal Joints PIPs in Rheumatoid Arthritis (RA) Patients: a Prospective Pilot Study
Condition:   Rheumatoid Arthritis Intervention:   Drug: Nerve block Sponsor:   Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials

TOLERA: Tolerance Enhancement in RA
Condition:   Rheumatoid Arthritis Intervention:   Drug: Abatacept Injection Sponsor:   University of Erlangen-Nürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Wright Foot & Ankle Post-Market Observational Study
Conditions:   Arthritis;   Rheumatoid Arthritis;   Fracture;   Trauma Injury;   Fusion of Joint Intervention:   Device: Foot and Ankle Devices Sponsor:   Wright Medical Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2019 Category: Research Source Type: clinical trials

Assessment of the Clinical and Medico-economic Impact of SinnoTest ® in Patients With Rheumatoid Arthritis
Conditions:   Arthritis, Rheumatoid;   Biological Therapy Interventions:   Diagnostic Test: Biotherapy Prescription with SinnoTest® software;   Drug: Patient Current Care Sponsor:   University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials